| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:56695546:2054 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:56695546:2054?format=raw |
LEADER: 02054cam a2200409 a 4500
001 4051220
005 20221027024711.0
008 941006s1995 dcuab b 101 0 eng c
010 $a 94037226
020 $a0841230730 (alk. paper)
035 $a(OCoLC)31378411
035 $a(OCoLC)ocm31378411
035 $9ALK3766HS
035 $a(NNC)4051220
035 $a4051220
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRC271.T38$bT38 1994
060 10 $aQV 269 T235 1994
082 00 $a616.99/4061$220
110 2 $aAmerican Chemical Society.$bMeeting$n(207th :$d1994 :$cSan Diego, Calif.)
245 10 $aTaxane anticancer agents :$bbasic science and current status : developed from symposia sponsored by the Divisions of Chemical Health and Safety, Medicinal Chemistry, and Organic Chemistry at the 207th National Meeting of the American Chemical Society, San Diego, California, March 13-18, 1994 /$cGunda I. Georg, editor [and others].
260 $aWashington, DC :$bThe Society,$c1995.
300 $axiii, 353 pages :$billustrations, map ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aACS symposium series,$x0097-6156 ;$v583
504 $aIncludes bibliographical references and indexes.
650 0 $aPaclitaxel$vCongresses.
650 12 $aPaclitaxel$xchemistry.$0https://id.nlm.nih.gov/mesh/D017239Q000737
650 12 $aPaclitaxel$xpharmacology.$0https://id.nlm.nih.gov/mesh/D017239Q000494
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aGeorg, Gunda I.$0http://id.loc.gov/authorities/names/n92097010
710 2 $aAmerican Chemical Society.$bDivision of Chemical Health and Safety.$0http://id.loc.gov/authorities/names/no94041552
710 2 $aAmerican Chemical Society.$bDivision of Medicinal Chemistry.$0http://id.loc.gov/authorities/names/n79099045
710 2 $aAmerican Chemical Society.$bDivision of Organic Chemistry.$0http://id.loc.gov/authorities/names/n80131453
830 0 $aACS symposium series ;$v583.
852 00 $boff,hsl$hRC271.T38$iT38 1994